Skip to content

This text should not show on a preview page

The information on this site is for healthcare professionals only.
Are you a healthcare professional?

No
This site is not currently optimised for Internet Explorer.
For best viewing, please use Chrome, Firefox, Edge, or Safari.
  • Let's talk  Knowledge
  • Let's talk  Events
  • Let's talk  Innovation
  • Let's talk  Videos
  • Let's talk  Key opinions
  • Let's talk  Teva
  • Let's talk  Sign up
  • Let's talk  Knowledge
  • Let's talk  Events
  • Let's talk  Innovation
  • Let's talk  Videos
  • Let's talk  Key opinions
  • Let's talk  Teva
  • Let's talk  Sign up
  • Home
  • Events

Let's talk Events

ERS 2020: COPD management and connected inhalers

ERS 2020: COPD management and connected inhalers

Events
ERS 2020: Connected inhalers in the clinic

ERS 2020: Connected inhalers in the clinic

Events
European Respiratory Society Congress 2019

European Respiratory Society Congress 2019

Events
Eiffel Tower, Paris, France

ERS 2018: Severe eosinophilic asthma and the future of asthma care

  • Asthma
Events 2 min read
Filter

Disease management

Technology

  • Let's talk  Contact
  • Let's talk  Legal notice
  • Let's talk  Privacy policy
  • Let's talk  Report Adverse Events
© 2021 Teva Pharmaceuticals Europe BV. All rights reserved. Reporting of suspected adverse events is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. To ensure correct adverse event reporting, healthcare professionals are encouraged to use the appropriate website for their National Authority.
Piet Heinkade 107, 1019 GM Amsterdam, The Netherlands.
Approval code: RESP-TPE-NP-00082 Date of preparation: July 2021

This website uses cookies to ensure you get the best experience on our website. Learn more in our cookie policy

Thank you for your visit.
You are now leaving the website.
Do you wish to continue?